Vaccine market and production capabilities in the Americas
Abstract In the Americas, The United States of America, Canada, Mexico, and Brazil are the top vaccine producers and the countries with the leading infrastructure for biological manufacturing. The North American countries have the most demanding legislation regulating and controlling these pharmaceu...
Published in: | Tropical Diseases, Travel Medicine and Vaccines |
---|---|
Main Authors: | , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doi.org/10.1186/s40794-021-00135-5 https://doaj.org/article/b05a00962c604acd84fbc83352d26e34 |
id |
ftdoajarticles:oai:doaj.org/article:b05a00962c604acd84fbc83352d26e34 |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:b05a00962c604acd84fbc83352d26e34 2023-05-15T15:07:16+02:00 Vaccine market and production capabilities in the Americas Esteban Ortiz-Prado Estefanía Espín Jorge Vásconez Nathalia Rodríguez-Burneo Nikolaos C. Kyriakidis Andrés López-Cortés 2021-04-01T00:00:00Z https://doi.org/10.1186/s40794-021-00135-5 https://doaj.org/article/b05a00962c604acd84fbc83352d26e34 EN eng BMC https://doi.org/10.1186/s40794-021-00135-5 https://doaj.org/toc/2055-0936 doi:10.1186/s40794-021-00135-5 2055-0936 https://doaj.org/article/b05a00962c604acd84fbc83352d26e34 Tropical Diseases, Travel Medicine and Vaccines, Vol 7, Iss 1, Pp 1-21 (2021) Vaccines Latin America Market Vaccine coverages Economic dependence Arctic medicine. Tropical medicine RC955-962 article 2021 ftdoajarticles https://doi.org/10.1186/s40794-021-00135-5 2022-12-31T15:18:35Z Abstract In the Americas, The United States of America, Canada, Mexico, and Brazil are the top vaccine producers and the countries with the leading infrastructure for biological manufacturing. The North American countries have the most demanding legislation regulating and controlling these pharmaceuticals’ distribution and production. Some Latin American countries rank in the top 20 of worldwide vaccine manufacturers, with Cuba, Brazil, México and Colombia have a self-sufficient vaccine production of 72.7%, 54,2%; 25%; and 7.7%, respectively, of the national vaccine demand. On the other hand, the rest of Latin American countries cannot satisfy their demand for vaccines, and most of their efforts are associated with the distribution within their health systems rather than in transferring technology. Based on this literature review, the results suggest an increasing growth vaccine demand, not only for their growing populations and previously established demand but also for the recently exerted pressure due to the COVID-19 pandemic. Because the American continent has a marked inequality between the hegemonic producers of vaccines, the exporters, and those that depend heavily on importing these products, this could assert technological dependence in countries with rapid population growth and jeopardize the effectiveness of the two vaccination plans. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Canada Tropical Diseases, Travel Medicine and Vaccines 7 1 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Vaccines Latin America Market Vaccine coverages Economic dependence Arctic medicine. Tropical medicine RC955-962 |
spellingShingle |
Vaccines Latin America Market Vaccine coverages Economic dependence Arctic medicine. Tropical medicine RC955-962 Esteban Ortiz-Prado Estefanía Espín Jorge Vásconez Nathalia Rodríguez-Burneo Nikolaos C. Kyriakidis Andrés López-Cortés Vaccine market and production capabilities in the Americas |
topic_facet |
Vaccines Latin America Market Vaccine coverages Economic dependence Arctic medicine. Tropical medicine RC955-962 |
description |
Abstract In the Americas, The United States of America, Canada, Mexico, and Brazil are the top vaccine producers and the countries with the leading infrastructure for biological manufacturing. The North American countries have the most demanding legislation regulating and controlling these pharmaceuticals’ distribution and production. Some Latin American countries rank in the top 20 of worldwide vaccine manufacturers, with Cuba, Brazil, México and Colombia have a self-sufficient vaccine production of 72.7%, 54,2%; 25%; and 7.7%, respectively, of the national vaccine demand. On the other hand, the rest of Latin American countries cannot satisfy their demand for vaccines, and most of their efforts are associated with the distribution within their health systems rather than in transferring technology. Based on this literature review, the results suggest an increasing growth vaccine demand, not only for their growing populations and previously established demand but also for the recently exerted pressure due to the COVID-19 pandemic. Because the American continent has a marked inequality between the hegemonic producers of vaccines, the exporters, and those that depend heavily on importing these products, this could assert technological dependence in countries with rapid population growth and jeopardize the effectiveness of the two vaccination plans. |
format |
Article in Journal/Newspaper |
author |
Esteban Ortiz-Prado Estefanía Espín Jorge Vásconez Nathalia Rodríguez-Burneo Nikolaos C. Kyriakidis Andrés López-Cortés |
author_facet |
Esteban Ortiz-Prado Estefanía Espín Jorge Vásconez Nathalia Rodríguez-Burneo Nikolaos C. Kyriakidis Andrés López-Cortés |
author_sort |
Esteban Ortiz-Prado |
title |
Vaccine market and production capabilities in the Americas |
title_short |
Vaccine market and production capabilities in the Americas |
title_full |
Vaccine market and production capabilities in the Americas |
title_fullStr |
Vaccine market and production capabilities in the Americas |
title_full_unstemmed |
Vaccine market and production capabilities in the Americas |
title_sort |
vaccine market and production capabilities in the americas |
publisher |
BMC |
publishDate |
2021 |
url |
https://doi.org/10.1186/s40794-021-00135-5 https://doaj.org/article/b05a00962c604acd84fbc83352d26e34 |
geographic |
Arctic Canada |
geographic_facet |
Arctic Canada |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Tropical Diseases, Travel Medicine and Vaccines, Vol 7, Iss 1, Pp 1-21 (2021) |
op_relation |
https://doi.org/10.1186/s40794-021-00135-5 https://doaj.org/toc/2055-0936 doi:10.1186/s40794-021-00135-5 2055-0936 https://doaj.org/article/b05a00962c604acd84fbc83352d26e34 |
op_doi |
https://doi.org/10.1186/s40794-021-00135-5 |
container_title |
Tropical Diseases, Travel Medicine and Vaccines |
container_volume |
7 |
container_issue |
1 |
_version_ |
1766338810436648960 |